Burning Rock Biotech Files 20-F Amendment
Ticker: BNR · Form: 20-F/A · Filed: Nov 26, 2024 · CIK: 1792267
Sentiment: neutral
Topics: annual-report, amendment, foreign-issuer
TL;DR
Burning Rock Biotech filed its 2023 annual report amendment (20-F/A) on Nov 26, 2024.
AI Summary
Burning Rock Biotech Ltd filed an amendment (Amendment No. 1) to its 20-F form for the fiscal year ending December 31, 2023. This filing, dated November 26, 2024, serves as an annual report under the Securities Exchange Act of 1934. The company is headquartered in Guangzhou, Guangdong, China.
Why It Matters
This filing provides updated annual financial and operational information for investors and regulatory bodies, offering insights into the company's performance and status as of December 31, 2023.
Risk Assessment
Risk Level: medium — As a foreign private issuer filing an annual report, the company is subject to specific disclosure requirements and potential regulatory scrutiny, and the amendment suggests potential updates or corrections to previously filed information.
Key Numbers
- 2023-12-31 — Fiscal Year End (The period covered by the annual report.)
- 2024-11-26 — Filing Date (Date the amendment was submitted to the SEC.)
Key Players & Entities
- Burning Rock Biotech Ltd (company) — Filer of the 20-F/A amendment
- 2023-12-31 (date) — Fiscal year end date for the report
- 2024-11-26 (date) — Filing date of the amendment
- Guangzhou, Guangdong (location) — Company headquarters location
FAQ
What specific information was amended in this 20-F filing?
The filing is an amendment (Amendment No. 1) to the Form 20-F, indicating that there were updates or corrections to the original filing for the fiscal year ended December 31, 2023. Specific details of the amendments are not provided in the header information.
What is the primary purpose of a Form 20-F filing?
A Form 20-F is an annual report required for foreign private issuers with securities registered in the United States, providing comprehensive financial and business information for the fiscal year.
When was Burning Rock Biotech Ltd's fiscal year end for this report?
The fiscal year end for this report was December 31, 2023.
Where is Burning Rock Biotech Ltd headquartered?
Burning Rock Biotech Ltd is headquartered at No. 5 Xingdao Ring Road North, International Bio Island, Guangzhou, Guangdong, China.
What is the SEC file number for Burning Rock Biotech Ltd?
The SEC file number for Burning Rock Biotech Ltd is 001-39316.
Filing Stats: 1,411 words · 6 min read · ~5 pages · Grade level 14.6 · Accepted 2024-11-26 08:24:32
Key Financial Figures
- $0.0002 — e Class A ordinary shares, par value US$0.0002 per share* BNR The Nasdaq Stock Mar
Filing Documents
- d869724d20fa.htm (20-F/A) — 53KB
- d869724dex121.htm (EX-12.1) — 10KB
- d869724dex122.htm (EX-12.2) — 10KB
- 0001193125-24-265669.txt ( ) — 321KB
- bnr-20241126.xsd (EX-101.SCH) — 4KB
- bnr-20241126_cal.xml (EX-101.CAL) — 1KB
- bnr-20241126_def.xml (EX-101.DEF) — 22KB
- bnr-20241126_lab.xml (EX-101.LAB) — 28KB
- bnr-20241126_pre.xml (EX-101.PRE) — 23KB
- d869724d20fa_htm.xml (XML) — 12KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Burning Rock Biotech Limited By: /s/ Yusheng Han Name: Yusheng Han Title: Chairman of the Board of Directors and Chief Executive Officer Date: November 26, 2024 2